This study, called PRORAD-5, is looking at a type of radiation treatment called Stereotactic Body Radiation Therapy (SBRT) for people with advanced prostate cancer. SBRT uses focused radiation in 5 sessions. The main goal is to see how safe this treatment is and if it causes any serious side effects, especially in the digestive system. Researchers will also look at how this treatment affects your quality of life, including urinary, bowel, and sexual function. You may be able to join if you have a confirmed diagnosis of prostate adenocarcinoma and meet specific tumor criteria. This study plans to enroll 70 participants.

Study design

This study is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 70 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Your safety and side effects will be monitored through study completion, which is an average of 1 year. Your quality of life will be assessed for up to 24 months after completing radiation therapy.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.